Humana CEO: We’ll Slow New Sales If Needed to Protect Quality
CFO Celeste Mellet said the insurer is “not seeing anything” suggesting medical and pharmacy cost growth will slow in the coming year
CFO Celeste Mellet said the insurer is “not seeing anything” suggesting medical and pharmacy cost growth will slow in the coming year
An academic researcher argues that business activity is rearranging incentives in healthcare
The new drug payment initiative is designed to negotiate fairer prices for Medicaid
Despite high enthusiasm among healthcare staff for GenAI, many organizations struggle with deployment challenges
At NAACOS meeting, LTC ACO’s Kristen Krzyżewski explains the savings opportunities available when taking a value-based care approach
Financial and policy trends are shifting the M&A landscape now, says a Kaufman Hall expert
Increasing costs are driven by chronic diseases, pharmacy expenses, and labor shortages
Collaborative for Healthy Rural America includes Lumeris, Teladoc Health, Nuna, Deloitte, and Unite Us
Macroeconomic signals and policy shifts are making things more difficult for hospitals
J. Marc Overhage, M.D., Ph.D., who led the development of the HDU Capability Model, will become CEO of the Consortium for State and Regional Interoperability in January